Skip to search formSkip to main contentSkip to account menu

AAV-DC-CTL Tumor Cell Targeting Therapy

Known as: ACTL Therapy, Antigen-specific Cytotoxic T Lymphocytes Induced by Dendritic Cells Infected by Recombinant Adeno-associated Virus Therapy 
A tumor-targeted therapy consisting of cytotoxic T lymphocytes (CTLs) that are exposed ex vivo to dendritic cells (DCs) transfected with a… 
National Institutes of Health

Search for papers about AAV-DC-CTL Tumor Cell Targeting Therapy

Search papers